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1. Introduction 
 
Epilepsy is the most common neurological disorder in dogs (Kearsley-Fleet et al., 
2013; Löscher, 1997; Thomas, 2010; Volk et al., 2015). It is characterized by 
recurrent seizures, which can have a focal or generalized semiology. Diagnosis and 
especially the management of the seizures remain challenging in some patients in 
veterinary neurology. It has been reported that over 30% of dogs are diagnosed with 
refractory epilepsy that does not sufficiently respond to anti- epileptic treatment 
(Martlé et al., 2014; Muñana et al., 2013). Surgical excision of the seizure focus is 
successfully performed in human patients with medically intractable epilepsy that 
arises from the hippocampus formation and associated structures with good long-
term prognosis for seizure reduction, or even full resolution of seizures. Comparable 
surgical treatment for dogs with intractable epilepsy is not yet established, but could 
represent a promising option for the control of seizures in canine patients, too. 
Whereas the hippocampus has been clearly identified as a seizure generator in cats, 
the same evidence in dogs is less conclusive, and the morphology and function of 
the hippocampus in dogs with seizures is focus of intensive research. Some dogs 
present with atrophy or diffuse hyperintensities in the hippocampus, which suggest 
structural and functional changes in that brain area. These findings indicate some 
role in seizure pathogenesis. However, it remains unclear if the hippocampus is 
primarily changed (i.e. hippocampus sclerosis) or if the hippocampus underwent the 
same negative influences as the rest of the brain tissue after chronic seizure activity. 
Conventional magnetic resonance imaging (MRI) techniques are not always capable 
to visualize minor structural changes in the brain but also mostly cannot confirm, that 
the lesions observed in the sequences are in fact the underlying cause of the 
epileptic discharges. Magnetic resonance spectroscopy (MRS) is a non-invasive, in-
vivo analytical technique obtained during standard MRI, which enables to observe 
the metabolic alterations in a specific region of interest in the brain. MRS is a relative 
new diagnostic tool in veterinary medicine and could be beneficial as a new 
evaluation method of the temporal lobe in epileptic dogs. In order to differentiate 
primary from secondary changes, spectra of the dogs with idiopathic epilepsy and 
generalized tonic-clonic seizures must be characterized as a baseline for future 
comparison. 
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The purpose of this prospective study was to evaluate the spectra of the common 
metabolites in the temporal region in dogs with non-lesional idiopathic generalised 
epilepsy using proton magnetic resonance spectroscopy (1HMRS). 
 
 
 
2. Literature review 
 
2.1 Definition of primary epilepsy 
 
Epilepsy is defined as a sudden, transient and abnormal phenomenon of a sensory, 
motor, autonomic, or psychic nature resulting from a transient brain dysfunction 
(Lorenz et al., 2011). The seizure can be caused by a secondary disease such as 
CNS infection, neoplastic disorders, intoxication or metabolic imbalances that all 
influence the membrane potential of the neurons. In primary epilepsy, no visible 
brain pathology can be diagnosed, which is why it is also often synonymously 
termed as idiopathic epilepsy. Following this definition, idiopathic epilepsy is 
diagnosed by exclusion of all possible secondary causes, and, in addition, based on 
the signalment, the typical age of onset, lack of interictal neurological clinical signs 
(DeLahunta & Glass, 2009; Dewey & da Costa, 2016). Idiopathic epilepsy is often 
age dependent and most dogs with primary epilepsy experience the first seizure at 
the age of 6 months to 6 years (Lorenz et al., 2011). The peak age of onset is at 1-3 
years. However, the strict time frame is increasingly a matter of debate as several 
studies on Labrador retriever and Beagle puppies described possible earlier onset of 
few months of age (DeLahunta & Glass, 2009; Lorenz et al., 2011). Nevertheless, 
compatible age together with a normal physical examination, normal neurological 
examination, and normal bloodwork including complete blood count, full chemistry 
panel with electrolytes, bile acid profile, and a urinalysis is one of the indicators for a 
presumptive diagnosis of idiopathic epilepsy.  
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2.2 Breed predisposition in idiopathic epilepsy 
 
Several canine breeds have a high incidence of seizure episodes, such as the 
Beagle, Belgian Shepherd, Belgian Tervuren, Bernese mountain dog, British 
Alsatian, Border collie, Dachshund, English springer spaniel, Finnish Spitz, Golden 
retriever, Irish wolfhound, Greater Swiss Mountain dog, Keeshond, Labrador 
retriever, Petit Briquet Griffon Vend´een, Shetland sheepdog, Standard Poodle, and 
Vizsla. However, any purebred or mix-breed dog can be affected with idiopathic 
epilepsy (DeLahunta & Glass, 2009; Dewey & da Costa, 2016). 
Recently, a couple of gene defects were identified in dogs with heritable seizures. A 
truncating mutation in LGI2 (Leucine-Rich Glioma-Inactivated Protein 2) gene 
causing a lower neuronal threshold in Lagotto Romagnolo breed has been 
recognised (Seppälä et al., 2011). LGI proteins have a role in a synaptic 
transmission and regulate the development of the glutamatergic synapses (Pakozdy 
et al., 2013). They are also a part of a synaptic protein complex of the voltage-gated 
potassium channels. Their malfunction enhances glutamatergic transmission and 
therefore, lowers seizure threshold. The same research group confirmed that 
homozygosity for a two-SNP haplotype within the ADAM23 gene conferred the 
highest risk for epilepsy in the Belgian Sheepdog (Seppälä et al., 2011). The product 
of this gene is also involved in a synaptic transmission. In the hippocampus, both 
ADAM and LGI proteins are widely distributed in the granule cells of the dentate 
gyrus and CA3 and CA1 pyramidal neurons (Kalachikov et al., 2002).  Although a 
genetic origin could not be found in other forms of idiopathic epilepsy, it is likely that 
in most, if not all epileptic diseases in dogs a genetic defect will be identified 
eventually. As the epileptogenic effect of these defects is caused by altered synaptic 
transmission and proceeds on the ultrastructural level in one-, or possibly multiple 
brain areas, such epileptogenic foci are beyond the structural changes that might be 
seen in the MRI. 
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2.3 Pathophysiology of primary epilepsy 
 
The exact underlying mechanisms of the epileptic seizures are not completely 
understood, although numerous studies helped to define the major processes 
responsible for pathological epileptic discharges (Chapman et al., 1998; Chen et al., 
2007; Vezzani et al., 1999). There are several reasons for the hyperexcitability of the 
neurons including lack of the neuronal inhibiting mechanisms, imbalance between 
the excitatory and inhibitory neurotransmitters or abnormal structure of ion channels. 
Moreover, the epileptiform activity can be a result of all these mechanisms 
simultaneously. The so-called “seizure threshold” is described as a level of neuronal 
inhibition, which maintains the neurons in a balanced state. The uncontrolled 
discharges in population of neurons are triggered by the disturbance in the neuronal 
environment, causing disproportion in the seizure threshold followed by neuronal 
excitation (DeLahunta & Glass, 2009). 
The neuronal environment in the brain tissue is kept stable by neurons, the neuronal 
lipoprotein cell membranes with ion channels, the accurate concentration of the 
electrolytes (sodium, chloride, potassium and calcium) and the neurotransmitters.  
The astrocytes play also an essential role in metabolizing many of the 
neurotransmitters via transmission of the metabolites and ions through the walls of 
the blood vessels (DeLahunta & Glass, 2009). One theory regarding the insufficient 
inhibition of the brain activity in the cerebral cortex refers to lacking amount of the 
principal inhibitory neurotransmitters including gamma-aminobutyric acid (GABA), 
glycine, taurine and norepinephrine (DeLahunta & Glass, 2009; Dewey & da Costa, 
2016). In the physiological environment, GABA is released into the synapse, where 
is attached to its receptors and monitors the passage of chloride through the ion 
channels, increases the potassium conductance and decreases the calcium entry, 
which has a slow inhibitory effect and stops the depolarisation. Alterations in GABA-
ergic function have been reported in both human and animal epilepsy studies (De 
Deyn et al., 1990; Podell, 1997). A reduced inhibition of GABA-ergic effect leads to 
epileptic seizures, while the improvement of the GABA-ergic inhibition reduces the 
epileptic discharges (Wong et al., 1982; De Deyn et al., 1990). The alteration in any 
of the mentioned mechanisms leads to imbalance in seizure threshold observed 
clinically as an epileptic seizure. 
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The neurons express the hyperactivity through the excessive electrical discharges or 
increased amount of excitatory neurotransmitters (aspartate, acetylcholine or 
glutamate), which lead to marked and prolonged depolarization (a paroxysmal 
depolarizing shift) of the group of neurons in a certain area (focal seizure) or in the 
whole cerebrum (generalised seizure). The excessive expression of glutamate can 
lead to neuronal loss and apoptosis by increasing intracellular calcium 
concentrations (Fountain et al., 1995; Olney et al., 1986;). This process results in 
neuronal damage or their dysfunction, in which specific neuronal populations, such 
as hippocampal neurons, display a selective vulnerability. A unique feature of the 
hippocampus is its capacity for neuroplasticity, which may account for its 
pronounced vulnerability to conditions as seizures. Neuroplasticity creates new 
synaptic connections, spreading and enhancing electrical activity.  
 
 
2.4 Morphology of the hippocampus 
 
The complex terminology of the hippocampus and its adjacent structures can be a 
challenge to understanding, further complicated by the differences between human 
and animal morphology. The term hippocampus was coined by ancient anatomists. 
Watching into of the lateral ventricle of human brains, they described a ridge of grey 
matter tissue, elevating from the ventricular floor, which resembled a sea horse lying 
upside down in the temporal horn. This impression can be explained by the unique 
shape of the human hippocampus, which considerably differs from that in other 
animals. The head of the sea horse was seen in the uncus (lat. hook), which is the 
rostral part of the hippocampus that bends where it merges with the 
parahippocampal gyrus. The thick head of the human hippocampus was described 
as the belly of the sea horse, the digitations at the surface of the hippocampus seen 
as the trunk rings of the animal (Spruston & Mcbain, 2007). The body of the human 
hippocampus swiftly tapers to the tail that winds around the thalamus as such as the 
animals would hold on a water plant. In domestic animals, the hippocampus neither 
has an uncus, nor digitations or lack a clearly distinct dorsal tapering into a tail. The 
two hippocampi rather have a uniform shape in their dorso-ventral course (Nickel et 
al., 2003). They lie on each side of the thalamus and rather resemble a pair of horns 
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on the head of a ram, which is why it was also referred to as the Ammon`s horn 
(Ram's horn) (Spruston & Mcbain, 2007). 
The hippocampus develops from the caudo-medial part of the cortical hemisphere 
that has infolded towards the lateral ventricle into a specialized area of allocortex, 
which comprises of two components. This is the actual hippocampus (hippocampus 
proper). The infolding process creates the hippocampal sulcus (also called 
hippocampal fissure) that separates the hippocampus from the laterally adjacent 
parahippocampal gyrus. At the beginning of their development, the cortical primordia 
of hippocampus and dentate gyrus are continuous. Then cells of this infolding 
cortical field detach, migrate to the end of the hippocampal cortex layer, surround it 
in the shape of a semicircle forming the dentate gyrus (Nickel et al., 2003). 
Macroscopically and microscopically the dentate gyrus and the hippocampus form 
an interlocking connection with one another (Figure 1). In addition, the term “dentate 
gyrus” originates on the observation of the human brain. After removal of the 
occipital pole of the hemispheres, the external surface of the dentate gyrus can be 
seen. In contrast to the smooth parahippocampal gyrus, the surface of the dentate 
gyrus has indentations resembling a row of teeth (lat.: dentes), which has led to the 
name of this structure. This characteristic indentation is also not seen in domestic 
animals (Nickel et al., 2003). 
Within the parahippocampal gyrus, allocortex and neocortex gradually merge by 
progressive alterations of the cytoarchitectonic composition of the hippocampus that 
runs first into the subiculum and then into the entorhinal cortex of the 
parahippocampal gyrus. The hippocampus (proper), the dentate gyrus, the 
subiculum and the entorhinal cortex are referred to as the hippocampal formation 
(Figure 2)(Jung et al., 2010; Uemura et al., 2015;). 
 
 
2.4.1 Cytoarchitectonics of the hippocampus proper 
 
In contrast to the six-layered isocortex of the forebrain, the architecture of the 
hippocampus and dentate gyrus is relatively simple. Each part consists of only one 
layer of neurons. The principle neuron type in the hippocampus is the pyramidal 
neuron, in the dentate gyrus, it is the granule neuron. Pyramidal neurons of the 
hippocampus have a large triangular cell body and two distinct dendritic “trees”, 
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emerging from the base, and from the apex of the soma (Lorente de No, 1934). The 
position of the cell bodies and the arrangement of their dendrites create the 
characteristic lamination of the hippocampus in sectional images. In Nissl stain, that 
highlights the cell bodies, the layers where the perikarya of cellular elements 
accumulate, forms the stratum pyramidale. The layer underneath the pyramidal cell 
layer is called the oriens layer (stratum oriens; latin: “oriēns” in this context means 
“originating”), which contains unmyelinated basal dendrites of the pyramidal cells 
and scattered cell bodies of inhibitory basket cells. The underlying layer that borders 
the ventricular surface of the hippocampus is the alveus (latin “alveus”: riverbed or 
channel). It is composed of the myelinated axons of the pyramidal cells.  
The area above the pyramidal layer adjoining the hippocampal sulcus is the 
molecular layer containing mostly the unmyelinated apical dendrites of pyramidal 
cells. It looks homogenous in Nissl stains. Staining techniques that highlight Zinc in 
synaptic connections with dendrites allow the identification of three sublayers 
characterized by different connectivity. Directly above the pyramidal cell bodies the 
straight apical dendrites of the pyramidal cells can be seen in almost parallel 
orientation. This layer is called the radiant layer (stratum radiatum) as the 
arrangement of the fibers in this layer reminded Cajal of sunrays (Ramon y Cajal, 
1893). The stratum radiatum contains septal and commissural fibers as well as 
schaffer collaterals. The next sublayer is the stratum lacunosum that contains 
incoming fibers from the entorhinal cortex (perforant path). The last layer is the 
actual molecular layer (stratum eumoleculare), that houses the arborizing apical 
dendrites of the pyramidal cells. The last two layers are often grouped together as 
the stratum lacunosum- moleculare (Amaral and Witter, 1989). 
 
 
2.4.2 Longitudinal divisions of the hippocampus (cornu ammonis fields) 
 
The layers of the hippocampus slightly differ in their arrangement in dependence of 
their position between the dentate gyrus and the subiculum. In the proximal aspect 
of the hippocampus Cajal identified another narrow zone just above the pyramidal 
cell layer and underneath the radiant layer. Due to the paucity of cells and fibers in 
this layer it doesn’t stain as intense as the other layers and appears translucent in 
the histological slides, which is why it was denominated stratum lucidum (latin: the 
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bright layer). The stratum lucidum contains unmyelinated axons originating in the 
granule cells of the dentate gyrus. These axons form characteristic dense synaptic 
connections (boutons) with the dendrites of the pyramidal cells that produce thin 
branches named “thorny excrescences” (latin: excrescēntia = abnormal growths 
(Amaral et al., 1989). These excrescences give the dendrites an appearance that 
reminded Cajal of a mosscovered tree (Raymon y Cajal, 1893). He introduced the 
name "mossy fibers" for axons that connect with the excrescences of the pyramidal 
cells. The presence or absence of the pyramidal cells with excrescences was the 
basis for the earliest classification of subfields in the longitudinal extension of the 
hippocampus in the rat as “regio superior” and “regio inferior” (Ramon y Cajal, 
1893). The two early subdivisions of Cajal were later further divided into four 
subfields based on pyramidal cell morphology. The term cornu ammonis was 
adopted in abbreviated form as CA (Cornu Ammonis) in naming the four subfields 
CA1-CA4. In rats, pyramidal cell bodies in CA1 are smaller than in the other 
subfields, have a triangular shape and tend to stain less intensely in Nissl 
preparations (Amaral et al., 1989; Lorente de No, 1934). In CA3, that contains the 
mossy fibers, the cell bodies are larger, take up more stain, and are quite densely 
packed to a narrow band of cells. CA2 is a sort of a boundary zone sharing features 
of CA1 and CA3. It does not contain mossy fibers, but pyramidal somata are large 
as in CA3. The CA2 field has been a matter of some controversy. Its boundaries to 
CA1 and CA3 are clear in rodent and human hippocampi, but its presence could not 
be proven with certainty in all mammalian species (Amaral et al., 1989). 
CA4 is easy to visualize. It is a loose segment of cells arranged around the end of 
CA3 that links up with the granular cell layer of the dentate gyrus. Unlike other 
pyramidal cells, the somata of CA4 do not form a recognizable layer. They are 
scattered among intertwined mossy fibers in the hilar region underneath the granule 
cell layer. The cells in CA4 do not have the characteristical pyramidal morphology, 
but are rather multipolar or fusiform neurons or have polymorph morphology 
(Lorente de No, 1934). Due to the unclear developmental origin and clear 
classification of the cells, the term CA4 has been abandoned from the modern 
anatomical terminology and was replaced by the term “endfolium” (latin: terminal 
leaf) of CA3. The cells of the endfolium are enclosed within the granular cell layer of 
the dentate gyrus. This area between the two blades of the granule cell layer is 
described as the hilus of the dentate gyrus (latin “hilum”: “small depression” or 
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“indentation”). Although actually different structures, the terms - hilus and endfolium 
are commonly used synonymous. Also the dendrites of CA4 are covered by 
abundant thorny excrescences where they form synapses with the axons coming 
from the granule cell layer of the dentate gyrus. 
 
 
 2.4.3 Cytoarchitectonics of the dentate gyrus (dentate fascia) 
 
The structure of the gyrus dentatus is simpler than of the hippocampus. Three layers 
are visible In Nissl stains. The main cell layer contains somata of very small granular 
neurons (stratum granulosum, latin “granulum”: grain).  It is a densely packed layer, 
whose shape is position- and also markedly species-specific. In dorsal slices of the 
rat’s hippocampus, it is presented as a more or less compressed “C” in the ventral 
(temporal) part of the hippocampus formation and as a “V” or a “U” in the dorsal 
(septal) part (Amaral et al., 2007). The limb of the granular cell layer, which is 
bounded between the CA3- and the CA1 field, is referred to as the supra-pyramidal 
layer or supra-pyramidal “blade”. The transition point adjacent to the end-folium is 
the crest of the layer, merging into the infra-pyramidal blade sitting below the CA3 
field. The granule neurons have a round to elliptical cell body, which is also smaller 
than the soma of the pyramidal cells, and give rise to axons forming only one cone-
shaped tree of spiny apical dendrites (Amaral et al., 2007). The stratum that 
contains these dendrites is relatively cell free. It is again called molecular layer 
analogous to the hippocampus, which can also be divided into two sublayers based 
on their connectivity. The area adjacent to the hippocampal sulcus is the outer 
molecular layer that receives fibers from the entorhinal cortex. The inner layer 
adjacent to the stratum granulosum contains fibers coming from the septal area and 
the hippocampus of the contralateral side (inner molecular layer). In between the 
two blades is the third layer of the dentate gyrus, the polymorphic cell layer (syn. 
stratum plexiforme; latin “plexiformis”: grid-like). It contains a variety of neuron types 
and intermixed abundant unmyelinated nerve fibers. It is now recognized that there 
is no clear cut difference or border between the pyramidal neurons of CA4 and the 
neurons of the polymorphic layer. They are now considered to be the same neuronal 
population. The neurons in the hilus are also called “mossy cells”, as they have 
analogous thorny excrescences on their dendrites as the neurons of CA3.  
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The dentate gyrus is one of three areas in the brain where neurogenesis occurs. 
Neuronal stem cells reside in a thin layer at the border between the granule- and 
polymorphic cell layer, which is called the subgranular zone. They provide a 
reservoir for the turnover and replacement of granular cells that are functionally 
integrated into the granular cell layer (Amaral et al., 2007). This process continues to 
occur throughout life and provides plasticity, which plays a crucial role in learning 
and memory. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Anatomical structures of the hippocampal formation in the rat brain. CA1: cornu 
ammonis field 1; CA2: cornu ammonis field 2; CA2: cornu ammonis field 3; CA4: cornu 
ammonis field 4; ento: cortex entorhinalis; fh: fimbria hippocampi; gde: gyrus dentatus; sub: 
subiculum (Schmidt et al., 2015). 
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Figure 2: T2-weighted transverse MR-image of the brain formation of the healthy beagle dog 
including the hippocampal within the temporal lobe (A). The corresponding histological slide 
in Nissl staining (Chreysl-Violet) shows all structural elements of the temporal lobe in detail 
(B) (Images: © Martin Schmidt). 
 
 
2.5 The role of the hippocampus in epilepsy 
 
The hippocampal formation, entorhinal cortex and amygdala, situated in the 
temporal lobe, have been a subject of interest in both human and veterinary clinical 
and experimental medicine studies (Ben-Ari,1980 et al.; Calcagnotto et al., 2000; 
Jung et al., 2010; Löscher, 1997; Pakozdy et al., 2011; Spencer et al., 1992). 
"Hippocampal sclerosis" has been shown to be one of the most outstanding 
neuropathological findings, causing refractory epilepsy in human patients (Blümcke 
et al., 2009; Hauser et al., 1991).  Hippocampal sclerosis is a result of the 
disorganisation of hippocampal cytoarchitecture, connectivity as well as gliotic 
atrophy of the pyramidal cell band of the cornu ammonis fields and in the 
hippocampus. It results in the deficit of almost 80% of the hilar somatostatin- 
immunoreactive inhibitory interneurons (Blümcke et al., 2002; Lanerolle et al., 1989; 
Mathern, 1995). The physiological role of the dentate gyrus is the transmission of 
the impulses that reach the hippocampus and further elaboration to the limbic 
cortices through the trisynaptic pathway (Behr et al., 1998). It undergoes structural 
remodelling of the dentate hippocampal circuits such as the loss of dentate hilus 
interneurons, presence of newly formed ectopic granule cells and mossy fibers 
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(Thom et al., 2009). Conversely, more recent papers suggest that the role of dentate 
gyrus is limited, showing similar hippocampal response in epileptic rats in 
comparison to control group (Ang et al., 2008).  
Extensive studies on hippocampus and its function in epilepsy have been conducted 
in human medicine. However, up to date are only few case reports from veterinary 
medicine available. The neuronal damage has been described in dogs with 
prolonged seizures (Montgomery et al., 1983; Yamasaki et al., 1991). Nevertheless, 
neurons tend to be extremely vulnerable to excitotoxic injury due to long-lasting 
seizure activity, which could indicate only disturbances as a result of prolonged 
epileptic activity (status epilepticus), rather than hippocampal sclerotic changes. The 
occurrence of hippocampal sclerosis as an underlying cause for seizure activity in 
dogs remains controversial  (Buckmaster et al., 2002; Koestner et al., 1989; 
Montgomery et al., 1983; Yamasaki et al., 1991). However, growing evidence 
suggests at least some role of the temporal lobe structures in canine epilepsy 
(Hasegawa, 2005; Schmidt et al., 2015). Hyperintense signals and atrophy of the 
hippocampus were demonstrated in MRI investigations of epileptic dogs (Kuwabara 
et al., 2010; Vullo et al., 1996) which is a sensitive and specific indicator of structural 
changes of the hippocampus in humans (Cendes et al., 1993; Cook et al., 1992; 
Jack et al., 1992). Furthermore, an increased apparent diffusion coefficient (ADC) 
was measured in the temporal lobe of epileptic dogs (Hartmann et al., 2017) which 
may be suggestive for underlying structural and/or functional abnormalities in this 
brain region. Experimental injection of kainic acid into the amygdala can produce 
complex partial seizures with associated rhythmic sharp waves in the left temporal 
region and bilateral volume loss of the temporal structures (Hasegawa et al., 2003). 
Finally, abnormal EEG activity, localized within the temporal lobe in dogs with 
natural occurring complex partial seizures could be found (Berendt et al., 1999) and 
was recently documented in association with hippocampal atrophy (Czerwik et al., 
2018).   
Even if the site of seizure onset is not in the hippocampus, it seems to be a route of 
propagation of the seizure discharge. In the epileptic hippocampus, the dentate 
gyrus undergoes changes including the loss of interneurons of the dentate hilus, 
appearance of ectopic granule cells, and sprouting of “mossy fibers” suggesting a 
remodelling of hippocampal circuits (Pitkänen et al., 2002).  Cell death and loss of 
the CA1 network integrity can alter the responses of CA1 pyramids from 
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predominantly inhibitory to powerfully excitatory can, and thereby create a self-
perpetuating loop that sustains seizure activity. 
If seizure activity is enhanced in the hippocampus – primarily or secondarily – it 
might be a promising target for therapeutic strategies in veterinary medicine.  
 
 
2.6 Refractory epilepsy 
 
The term refractory epilepsy is used in veterinary medicine to describe the condition, 
where the patients do not respond to treatment of two or more conventional 
antiepileptic drugs and suffer from frequent severe seizures. The 
pharmacoresistance occurs in approximately 20-30% of epileptic dogs (Lane et al., 
1990). Furthermore, less than 50% successfully treated dogs remain entirely 
seizure-free without unacceptable medication-related side effects including sedation, 
ataxia, polydipsia, polyphagia, hepatotoxicity and bone marrow suppression (Sander 
et al., 1993).  
The inadequately treated epilepsy in both human and veterinary patients tends to 
worsen over time. Proposed theories regarding refractoriness involve mirroring and 
kindling. Kindling is termed as the phenomenon in which the constantly generated 
seizures from the epileptic focus lengthen in duration and the behaviour of seizure is 
enhanced until a plateau is reached. This is due to the repeated stimulation of the 
previously non-hyperexcitable neurons, which turn into a group of hyperexcitable 
neurons within a cerebral hemisphere. Mirroring has a similar mechanism of action 
to kindling, but involves recruitment of neurons into the seizure focus from the 
opposite cerebral hemisphere via the corpus callosum (Bertram et al., 2007; Dewey 
& da Costa, 2016). These processes change the ability of the brain to limit seizures. 
The refractory cases are particularly difficult to manage, thus additional diagnostic 
and therapeutic approaches need to be developed in order to improve the patient’s 
quality of life and to plan the first epilepsy surgeries in veterinary medicine. 
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2.7 MRI abnormalities in dogs with seizures 
 
Magnetic resonance imaging technique is frequently used as a diagnostic tool for 
dogs with epilepsy. Next to the exclusion of structural or metabolic brain diseases, 
lesions attributed to seizure activity affecting different regions of the human and 
canine brain can be observed. The lesions are usually hyperintense on T2-weighted 
images (T2W), typically affecting the temporal and piriform lobes, hippocampus or 
cingulate gyri in the brain (Chan et al., 1996; Schmidt et al., 2015; Yaffe et al., 
1995). As the hyperintensities are usually reversible and resolve between 10 to 16 
weeks following seizures (Mellema et al., 1999) it is assumed, that they represent 
regional cytotoxic oedema due to regional ischemia, although degenerative 
histologic changes in neurons have also been described (Chan et al., 1996; Sloviter 
et al., 2008). In some cases, the observed changes are permanent and tend to 
worsen over time (uni- or bilateral ventriculomegaly secondary to hippocampal 
atrophy) and might be representing the hippocampal sclerosis (Figure 3) (Czerwik et 
al., 2018; Hartmann et al., 2017; Schmidt et al., 2015). 
 
. 
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Figure 3: MR initial imaging study on a dog with generalised epileptic seizures (T2-weighted 
transverse and dorsal sequence (a-d) (i-l) with unilateral hyperintense lesions at the level of 
hippocampus, similar to temporal lobe sclerosis, described in human medicine. In the control 
study, ventriculomegaly secondary to hippocampal atrophy and hyperintensity at the level of 
cornu ammonis were observed (e-h) (m-p) (Schmidt et al., 2015). 
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2.8 Magnetic resonance spectroscopy 
 
Magnetic resonance spectroscopy (MRS) is a unique diagnostic MRI technique, 
based on nuclear magnetic resonance (NMR) that allows quantitative in vivo 
assessment of concentration of metabolites in various tissues. It provides 
biochemical information about specific regions within the brain tissue of interest by 
detecting the resonance frequencies of metabolites. A quantitative evaluation of the 
specific substances with MRS can be used for differentiating several brain lesions, 
such as tumours, seizure-onset zone, strokes, inflammation, or oedema. It can be 
also applied as a tool to define brain maturation and aging. The first use of the proton 
MRS in vivo was reported by Behar, who examined rats at 8.5 T MRI, and the first 
spectra of metabolites including N-acetylaspartate, glutamine, glutamate, creatine, 
choline and lactate, were demonstrated in the rat brain (Behar et al., 1983). Magnetic 
resonance studies in laboratory animals for medical research as a model of human 
disease are performed with routine since then (Chatham et al., 2001; Hiremath et al., 
2007; Neppl et al., 2001). The introduction of high field MRI in veterinary radiology 
and the improvement of acquisition and analysis techniques have also driven the 
evaluation of the technique for clinical studies in companion animals. Up to date 
available canine MRS studies include MRS spectrum analysis in hepatic 
encephalopathy (Carrera et al., 2014; Nyberg et al., 1998;) or tick-borne encephalitis 
(Sievert et al., 2016). Magnetic resonance spectroscopy have also been used as a 
monitoring treatment tool in dogs with meningoencephalitis of unknown origin 
(Beckmann et al., 2015). Recently data on 1HMRS of the brain of healthy beagles 
have been reported and the differences in regional metabolite concentrations have 
been demonstrated using 3 Tesla and 7 Tesla MRI (Ober et al., 2013; Ono et al., 
2014; Martin-Vaquero et al., 2012). Other than these studies, MRS is a technique in 
its infancy in veterinary medicine. 
 
 
2.8.1 Physical principles of MR-spectroscopy 
 
The physical mechanism of magnetic resonance imaging is based on the absorption 
of electromagnetic waves by the non-zero spin atomic nuclei (e.g. 1H, 31P). Most 
MRI studies have been performed using the hydrogen nucleus 1H due to its high 
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sensitivity to bound in tissue water which provides also the basis for MR imaging, so 
the hardware can be obtained for both techniques simultaneously. Hydrogen is also 
dominant in the most metabolites in the brain tissue. Other nuclei (phosphorus-31, 
carbon-13, nitrogen-15) are rarely used because of the lower sensitivity, worse 
special resolution and natural abundance in comparison to hydrogen which prolongs 
the scan time and enlarges the voxel size (Barker et al., 2011).  
The absorbed electromagnetic waves are stored as energy and then returned in the 
process of relaxation during recovery of the spins to thermodynamic balance. Nuclear 
spins behave in the magnetic field like magnets that become polarized parallel or 
antiparallel. Energy radiated by these nuclei, after applying the radiofrequency 
electromagnetic waves typical for individual chemical compounds, is absorbed by 
spins in a magnet, which transform from the antiparallel to the parallel state and 
could be detected by the MR spectrometer in MRI receiving coil (Barker et al., 2011; 
Stagg et al., 2013). This resonant phenomenon and the resulting emitted 
radiofrequency signal is the essential principle of NMR. 
In order to obtain good quality spectra, magnet field of 1.5 to 7 T in field strength 
should be used. The lower field scanners are disadvantageous due to lower 
sensitivity, which arises from the proportion of energy per absorption and emission to 
frequency. The quality of the NMR spectrum increases linearly with increasing the 
strength of field (Stagg et al., 2013). 
A series of substances that play an important role in neurotransmission and brain 
energetics can be detected by MRS in vivo. Unfortunately, the majority of metabolites 
have concentrations below the millimolar detection limit. Nucleus’ MR frequency of 
metabolites during screening is termed as chemical shift and stands for the main 
concept of MRS. 1H chemical shifts acquired in vivo are valued as differences of 
parts per million (ppm). These compounds can be distinguished from each other and 
seen as characteristic peaks at different frequencies on the x-axis of the spectrum 
(Stagg et al., 2013). All the resonances of the metabolites are collected concurrently 
in the time domain, which makes it impossible to interpret for a human eye.  
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Figure 4: An example of a MRS spectrum obtained as a result of Fourier transformation, 
recorded at 3T with an echo time of 30ms (Barker et al., 2011). 
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The method called Fourier transformation (FT) needs to be obtained, so that the 
actual spectrum can be generated. Fourier transformation converts the signal 
intensity from time domain into frequency domain. It allows acquiring all signals of the 
metabolites in the field of interest at once. Because the Fourier transformation is a 
form of Gaussian fitting itself, this model is used most broadly due to obtaining the 
sharpest- shaped peaks in the frequency domain (Figure 4)(Stagg et al., 2013). 
 
 
2.8.2 Quantification of MR Spectra 
 
The aim of the MRS is the non-invasive quantification of the chemical compounds in 
the field of interest in the brain. However, the spectra acquired from a desired area of 
the brain contain the combined information from all distinguished metabolites as sum 
of their particular concentrations. Moreover, a number of additional, unwanted signals 
from sources other than the brain metabolites such as lipids, water and other 
macromolecules are visible in the acquisition and have to be taken into account when 
obtaining the MRS data. The spectra are also dependant on the technique that is 
used to obtain them, including the strength of field and a choice of echo time for the 
examination. Therefore, different methods of quantification and the same parameters 
need to be acquired in order to get reliable results. The most popular quantification 
method is a linear combination of model (LCModel). After the necessary scaling, the 
area under each peak is proportional to the number of protons with resonance 
frequency, which allows the evaluation of the relative concentrations of known 
substances. For each metabolite, the obtained scaling links to an apparent 
concentration (Figure 5) (Stagg et al., 2013).  
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Figure 5: Quantification of 1H MR spectra as a linear combination of model spectra (LCModel). 
(A) 1H spectra comprise a sum of signals from the apparent neurochemical profile. (B) The 
spectrum contains a combination of the spectral patterns from individual metabolites. The 
necessary scaling corresponds to the apparent concentration of the substances. (Stagg et al., 
2013). 
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The detection of the brain metabolites in brain tissue is challenging, as the 
concentrations are 103-104 times smaller in contrast to water molecules which 
dominate in volume, occupying around 70-80% of the grey and white matter. When 
the water peak remains unsuppressed, it overlaps all the relevant metabolites for the 
examination. For this reason, direct water suppression needs to be applied before, 
thus the metabolites signals can remain unaffected and water signal saturated. 
Most of the metabolite peaks consist of over 10 individual peaks, so the total number 
of defined peaks would be too large to specify the precise value. Therefore, special 
fitting method called basis spectrum fitting is required in order to present an 
individual metabolite’s spectral shape. This technique is usually proceeded 
automatically and involves fitting the entire spectrum as a linear combination of the 
basis spectra of all the molecules (Figure 6). 
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Figure 6: The method of basis spectrum fitting. The entire spectrum is fit to a linear 
combination of model spectra or basis spectra. Each basis spectrum corresponds to an 
individual metabolite, and the amplitude of the basis spectra represents the metabolite 
concentrations (Stagg et al., 2013). 
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The unwanted macromolecules can be simply separated from measured peaks by 
applying long echo time sequences where they are almost completely eliminated. 
Almost all macromolecules (MM) have short relaxation times (~250ms) which makes 
then invisible in comparison to other substances (NAA, Cr, Cho) that have 
TE~1500ms (Stagg et al., 2013). 
Magnetic resonance spectroscopy can be proceeded in two different ways: single-
voxel acquisition and multivoxel acquisition. With single voxel localization technique, 
a voxel (a volume of space) is applied in the tissue of interest and the proton signal in 
the voxel is used to produce a single spectrum. It is desirable to gain the information 
from a specific brain area due to extensive cellular heterogeneity. In practice, two 
pulse techniques are mostly used: Point Resolved Spectroscopy Sequence (PRESS) 
and Stimulated Echo Acquisition Mode (STEAM). The single-voxel technique is 
relatively easier to interpret and can be proceeded in shorter scanning time, as the 
signals from other brain regions are being isolated. The sensitivity to artefacts is also 
lower in comparison to multivoxel sequences. Single-voxel spectroscopy is a 
recommended approach to obtain the data in epileptic patients, that need to be 
scanned in the anaesthesia (Stagg et al., 2013). 
Both techniques have been a subject of a constant comparison, nevertheless PRESS 
sequence is more frequent applied because of its relative insensitivity to motion and 
instability of the system. The multivoxel technique allows the definition of the multiple 
areas of the brain by applying numerous voxels in single sequence. The greatest 
limitation of this technique is relatively long examination due to combined acquisition, 
which prolongs the anaesthesia of the patient. The other limitation is the 
heterogeneity of the scanned tissue and some amount of signal obtained from 
outside the voxel area, which should be considered when obtaining the metabolite 
concentrations.  
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2.8.3 Major metabolites 
 
The major brain metabolites analysed with long echo time 1HMRS of brain tissue 
using 1.5 Tesla MRI include N-acetyl aspartate (NAA), choline (Cho) and creatine 
(Cr), as these have the most prominent and readily identifiable peaks (Figure 7). 
These three large singlet resonances dominate at long echo time times, because of 
T2-decay and scalar evolution, which makes it difficult to observe the other 
macromolecules (Stagg et al., 2013). Regional metabolite variations are observed 
both in human and veterinary patients (Carrera et al., 2014; Warrington et al., 2013), 
also change with brain development and aging (Chiu et al., 2014).  
Other brain metabolites can be also estimated using MRS, however the accurate 
quantification is currently difficult due to the use of special sequences and particular 
echo time. These neurochemicals, currently described as nuisance signals, are 
glutamine, glutamate, lactate, lipids, myo-inositol, gamma-aminobutyric acid (GABA), 
alanine, and leucine. 
 
 
 
 
 
Figure 7: Spectroscopic peaks of N-acetyl aspartate (NAA), choline (Cho) and creatine (Cr) 
obtained with long echo time 1HMRS of canine brain tissue at the level of posterior 
hippocampus and amygdala. 
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The increasing availability of new ultra-field scanners is promising to better 
investigate the clinical application of these markers in veterinary medicine. The peak 
intensity of the spectra alone is meaningless and presented in arbitrary units. This 
signal can be influenced by several parameters involving the placement and size of a 
voxel, coil sensitivity, type of the scanner the strength of field and receiver gain. The 
observed peak intensity needs to be transformed into a significant value by using the 
comparison to the metabolite reference peak, which is relatively stable in the 
examined tissue.  
Spectral quantification is in principle a straightforward process. However, in the 
clinical use it is more problematic because of the presence of artefacts, complex 
spectral line shapes, overlapping peaks, different times, relaxations and 
macromolecule signal contaminations.  
 
 
2.8.3.1 N-acetyl aspartate (NAA) – the neuronal marker 
 
N-acetyl aspartate (NAA) stands for the most reliable marker of neuronal function and 
integrity and is considered one of the most abundant amino acids in the central 
nervous system. Other non-neural tissues have relatively small concentrations of 
NAA, below 40-50 µM (Miyake, 1981).  
NAA it is referred to as a precursor for the biosynthesis of the neuronal peptide N-
acetylaspartyglutamate (NAAG) and a marker of nerve cells in the nervous system 
(Figure 8)(Moffett et al., 2013; Stagg et al., 2013). However, the quantification of 
NAAG is more difficult because of a smaller size of a peak, which makes NAA the 
main interest of MRS studies.  
The role of NAA in the brain is not fully recognised, it has been found in neurons, 
dendrites and axons during immunocytochemical staining techniques in a nervous 
system of  humans, rats and cows, and dogs (Harris et al., 2006; Moffett et al., 1993;  
1995; Nadler et al., 1972; Urenjak et al., 1992). The concentration was however 
undetectable in astrocytes and mature oligodendrocytes (Urenjak et al., 1992).  
NAA signal peak is detected at 2.02 ppm and is more defined in contrary to the 
spectroscopic peaks of creatine and choline. It is believed that the level of NAA 
represents neuronal activity or neuronal loss in various neurological diseases (e.g. 
epilepsy, brain tumours, inflammation)(Hammen et al., 2012). It is not entirely 
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investigated whether the loss of NAA in the brain results from increased catabolism 
or decreased synthesis. In 1987, Hagenfeldt proved that NAA is catabolised by the 
enzyme called aspartoacylase (ASPA) in neurological disorders (Hagenfeldt et al., 
1987).  
N-acetyl aspartate was found decreased in various neurological diseases including 
epilepsy, presenting neuronal injury (Harris et al., 2006; Moreno et al., 2001; Riederer 
et al., 2006; Savic et al., 2000; 2004).  
The concentration of N-acetylaspartate in neuronal mitochondria in the human brain 
was evaluated to be approximately 12mmol/L (Rigotti et al., 2007). In the rat brain the 
concentration ranges between 9.2- 9.3 mmol/L (Mlynarik et al., 2008). Recently, 
values for NAA concentration in a brain of healthy beagles were estimated ranging 
from 7.17 mmol/L to 7.90 mmol/L, depending on the brain region (Carrera et al., 
2014). However, in a previous study on 10 healthy beagles, the mean NAA 
concentrations were at the level of 4,615 (Warrington et al., 2013). These 
concentrations varied significantly and were not normally distributed. To prevent 
measurement bias ratios of NAA-to-choline, mean of 1.294 (minimum 0.796 to 
maximum 2.318) and NAA-to-creatine, mean of 1.559 (minimum 1.145 to maximum 
2.167) were proposed as a reference values (Warrington et al., 2013).  
There are multiple theories about the actual function of NAA. It is responsible for 
supplying acetate groups for the synthesis of acetyl CoA (Burri et al., 1991; Mehta et 
al., 1995) and also involved in the synthesis of myelin and lipids in the CNS (Harris et 
al., 2006; Moffett et al., 2007).  
The first reports on 1HMRS in human patients with temporal lobe epilepsy showed a 
significant reduction of NAA in the hippocampus, suggesting temporary or 
permanent neuronal dysfunction in this area (Bernasconi et al., 2003; Simister et al., 
2003).  
MRS technique was similarly found valuable in lateralizing abnormalities regarding 
seizure onset in some patients with temporal lobe epilepsy, also in cases where the 
MRI was structurally normal. It was confirmed, that the metabolite abnormalities can 
occur uni- or bilaterally, mostly with significant reduction of NAA in comparison to 
control values (Aziz et al., 2016; Cendes et al., 1994; Connelly et al., 1994; 
Hetherington et al., 2007; Mueller et al., 2001). The bilateral changes of NAA can 
stand for a bilateral sclerosis or metabolic impairment as a result of the seizure in 
the epileptic side of the hippocampus propagating to the other side. This metabolic 
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disturbance represents rather a temporary dysfunction of neurons on the 
contralateral side and can improve over time after hippocampus surgery on the more 
affected side (Cendes et al., 1997; Vermathen et al., 2002). Even if in only small 
group of patients the epileptogenic focus was successfully lateralized, these patients 
had excellent surgical outcome (Kantarci et al., 2002). 
NAA is a highly sensitive parameter. Its concentrations depend on the region, 
duration and therapeutic control of seizures. The NAA levels in a suspected 
epileptogenic region were found within the normal limits in patients with well 
controlled seizure activity. In patients, that did not respond to treatment or have not 
been treated so far, it was perceived that the NAA/Cr ratio can worsen over time, 
implying the progression of the hippocampus sclerosis or atrophy, whereas in 
successfully treated patients NAA level can improve over time suggesting rather 
reversible neuronal dysfunction than neuronal loss (Bernasconi et al., 2002; 
Hammen et al., 2012). Moreover, the lesions observed in MRI do not necessarily 
have to be involved in the aetiology of the epileptic seizure and show also normal 
levels of NAA (Kuzniecky et al., 1997).  
N-acetylaspartate has been evaluated quantitatively as a concentration or as a ratio 
to creatine (NAA/Cr), as creatine believes to be a stabilization factor for many 
bioenergetic parameters and was found mostly in astrocytes. NAA/Cr ratio can be 
calculated with the purpose of presenting the neuronal metabolism and its 
dysfunction (Guevara et al., 2010; Maniega et al., 2008; Suhy et al., 2000). NAA/Cr 
ratio was also found relatively stable in a tissue containing cerebrospinal fluid, as it 
comprises only minimal amount of these metabolites. Spectroscopic abnormalities 
were found not only in a small area of hippocampus, occupying only some part of 
the temporal lobe, but also in the whole temporal lobe. These findings correlate with 
PET technique, and are due to the extensive hypometabolism in this area 
(Bernasconi et al., 2003; Simister et al., 2003). 
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Figure 8: NAA synthesis in the neuron. Acetyl CoA derived from pyruvate in neuronal 
mitochondria can be oxidized for ATP production in the TCA cycle, or it can be utilized by two 
different enzyme pathways to produce metabolites for export to the cytoplasm. Acetyl CoA 
and oxaloacetate can be converted to citrate via citrate synthase (red pathway), or acetyl CoA 
and aspartate can be converted to NAA via Asp-NAT (blue pathway). NAA is also synthesized 
in the endoplasmic reticulum by cytoplasmic Asp-NAT using acetyl CoA derived from citrate. 
Citrate is then metabolized to acetyl CoA within the cell where it was synthesized, whereas 
NAA is predominantly transported to other cells such as oligodendrocytes for metabolism. 
AAT, aspartate aminotransferase; AKG, alpha-ketoglutarate; Asp, aspartate; Asp-NAT, 
aspartate N-acetyltransferase; CL, citrate lyase; CS, citrate synthase; Glu, glutamate; Mal, 
malate; OAA, oxaloacetate; PDC, pyruvate dehydrogenase complex (Moffett et al., 2013). 
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2.8.3.2 Choline (Cho) 
 
Choline is an essential metabolite playing a complex function in the neuronal tissue. 
The main roles include the synthesis of cell membranes and its degeneration 
(membrane turnover). Moreover, Cho is a precursor of phosphocholine and 
acetylcholine and is involved in lipid transport and methyl- group metabolism 
(Loffelholz et al., 1993). Choline itself is absorbed from food, but also synthetized de 
novo and consequently bound in the phospholipids. 
The signal peak of Choline (Cho), marked at 3.20 ppm is heterogeneous 
representing choline, phosphocholine (PC) and glycerophosphocholine (GPC) 
(Barker et al., 1994; Miller et al., 1996). The concentration of Cho represents cellular 
density and cell water turnover and it differs depending on the localisation. In the 
temporal lobe, the increased concentration level of choline is caused by accelerated 
phospholipid turnover and disruption in cellular membrane integrity in many 
neurological disturbances including neoplasia, ischemic injury and demyelination 
(Aziz et al., 2016; Farber et al., 1981; Van der Knaap et al., 2003). High 
concentration of choline has been found in glial cells. It may be also elevated in 
some diseases with active demyelinating process including multiple sclerosis 
(Arnold et al., 1992; Bitsch et al., 1999; Valenzuela et al., 2001). The changes in 
concentration can also be adaptive, suggesting the normalisation of the metabolic 
processes within time (Nordahl et al., 2005).  
The mean choline concentration in the brain of the healthy dogs is 2.3 (±0.17mM) 
(Carrera et al., 2015). According to Warrington, the mean of choline-to-creatine ratio 
in 10 healthy beagles at an long echo time of 144 milliseconds was 1.240 (minimum 
0.787, maximum 1.838) at the level of temporal lobe (Warrington et al., 2013).  
 
 
2.8.3.3 Creatine (Cr) 
 
Creatine in brain tissue is involved in transport, regulation and storage of cellular 
energy. Creatine is found in many metabolically active tissues including brain, heart 
and muscles. The appearance of Cr is both from endogenous synthesis and dietary 
products. Creatine plays essential role in energy synthesis being converted by 
creatine kinase (CK) to phosphocreatine (PCr) which is directly used in a production 
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of adenosine triphosphate (ATP) (Figure 9)(Stagg et al., 2013; Steen et al., 2010). Cr 
is supplied by creatine transporter (CRT) to the brain via blood-brain barrier 
(Braissant, et al., 2001). In adults, this mechanism is becoming insufficient within 
time, therefore an extra endogenous synthesis of Cr within the brain is used (Ohtsuki 
et al., 2002; Perasso et al., 2003). Cr is synthetized in axonal mitochondria, 
oligodendrocytes, dendrites, synapses and neuronal cell bodies. 
The deficiency in Cr in a developing brain causes disturbance in axonal growth and 
axonal pathways plus reduced synaptic density which leads to mental retardation 
(Khwaja et al., 2008). In an adult brain, insufficient Cr synthesis and transport leads 
to deficiency in cellular energy homeostasis which causes mitochondrial dysfunction 
and further trigger to necrotic and apoptotic cell death (Desagher et al., 2000; Green 
et al., 1998; Roy et al., 2000). The clinical signs of this distortion include involuntary 
dyskinetic-dystonic movements, mental disability and epilepsy (Battini et al., 2002; 
Kleefstra et al., 2005; Mercimek et al., 2006; Rosenberg et al., 2004; Schulze et al., 
1997; Stockler et al., 2007).  
The creatine and phosphocreatine (Cr) is presented as a complex spectroscopic 
peak, observed at 3.03 parts per million (ppm). These two metabolite peaks overlap 
strongly on the spectrum and cannot be separated by any of the fitting methods.  
Total creatine is often applied as an internal reference for MRS due to its relative 
stability in both normal and pathological brain tissue (Condon et al., 2011; Connett et 
al., 1988; De Stefano et al., 2002; Tartaglia et al., 2002). The concentration of Cr in 
dogs in the basal ganglia was found to be at 7.12 mmol/L in the left hemisphere, and 
7.30 mmol/L in the right hemisphere (Carrera et al., 2015). The concentration of Cr in 
the cerebrospinal fluid has been proven to be negligible, therefore trace amount of 
CSF inside the applied voxel for the examination does not change the calculation of 
chosen metabolites (Hetherington et al., 1996). 
Cr spectrum signal was also found significantly reduced in magnetic resonance 
spectroscopy in animal models of epilepsy (Hiremath et al., 2007) and in a canine 
model of PTY-induced generalized seizures (Neppl et al., 2001) and other human 
studies including stroke (Gideon et al., 1994; Lauriero et al., 1996; Lei et al., 2009; 
Mathews et al., 1995) and hyperammonemia (Braissant et al., 2002; 2010).  
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Figure 9: Metabolism of neuronal creatine.  
Phosphocreatine (PCr) generated by mitochondria diffuses in the astrocytic processes where 
it is degraded by CK-B to deliver ATP. Creatine (Cr), formed by the removal of phosphate from 
PCr, diffuses into the mitochondria. This local energy is required for the Na+/K+-ATPase, 
which removes K+ generated during axonal electrogenesis from the extracellular space, and 
establishes the Na+ gradient required for Na+-dependent glutamate uptake by astrocytes. 
Transcription of CK-B appears to be mediated by cAMP (Steen et al., 2010). 
 
2.8.4 Internal metabolite referencing 
 
The absolute metabolite quantification can be obtained in different ways. One of the 
methods widely used is the acquisition of the resonance amplitudes as rations rather 
than absolute concentrations, with the understanding that most factors affecting 
resonance amplitude are homologous for all metabolite resonances in the spectrum. 
This is because limited data on absolute quantification of metabolite concentrations is 
available and significant differences in absolute values varying significantly on the 
type of the scanner are presented in presented studies. Furthermore, several 
advanced spectral fitting techniques must be carried on in order to obtain relevant 
measurements.  
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The quantification of compounds is performed by comparison the metabolite of an 
interest (expressed in the numerator) with a reference metabolite (expressed in the 
denominator). The reference compound is chosen basing on its relative stability in 
the examined tissue. Creatine is often presented as a reference parameter because 
of high impact in bioenergetics and relatively stable value (Connett et al., 1988).  
Mostly described metabolite concentration ratios include the NAA-to-choline, NAA-to-
creatine, and choline-to-creatine ratios. The generally accepted values determined 
using 1HMRS in the brain of heathy human patients are 1.6, 2.0, and 1.2, respectively 
(Alger et al., 2010). However, the latest studies in veterinary medicine presented that 
the comparison of the values to humans, assessed using 1HMRS, should be done 
with caution due to significant differences in ratios between the healthy human and 
canine groups (Warrington et al., 2013). In latest veterinary studies, no significant 
differences in ratio values between the sexes and the hemispheres in the canine 
healthy brain were noticed (Carrera et al., 2015). 
 
2.8.5 MRS methodology on animal models of epileptogenesis 
 
MRS methodology for animal models in human brain diseases has been extensively 
studied in order to provide result for the clinical studies. MRS was first used as 
diagnostic tool for assessment of animal model of epilepsy on rats the early 1980s. 
In the performed studies on 31P MRS it was first noticed, that status epilepticus is 
associated with the reduction of phosphocreatine (PCr) and occurrence of cerebral 
acidosis (Petroff et al., 1984). More recent studies on rats showed a significant 
decrease of NAA in both, the immediate days and chronically after status epilepticus 
that link with seizure-related injury (Hiremath et al., 2007; Filibian et al., 2012).  
Preliminary results of a detection of postictal perturbances in cerebral metabolism in 
prolonged general seizures in 5 mixed-breed dogs using MRS at field strengths of 
0.5 Tesla were described by Neppl (Neppl et al., 2001). Mean glutamine and 
glutamate (glx) concentration was significantly decreased in the postictal phase in 
these patients. Mean NAA concentration was not statistically significant in the 
mentioned study.  
Magnetic resonance spectroscopy was proposed as a possible useful tool in 
diagnosing epileptic dogs (Condon et al., 2011; Rusbridge et al., 2015). To author’s 
knowledge, no reports presenting use of magnetic resonance spectroscopy at field 
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strengths of 1.5 Tesla to evaluate regional differences in idiopathic epilepsy in dogs 
have been published up to date. 
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3. Research study 
 
3.1 Aim of the study 
The aim of our study was to evaluate the interictal metabolic activity of the temporal 
lobe region in dogs with idiopathic epilepsy and generalized tonic-clonic seizures 
using 1H single voxel magnetic resonance spectroscopy compared to a group of 
clinically sound control dogs. We therefore describe the metabolite ratios obtained 
bilaterally, symmetrically at the level of temporal lobe and posterior part of 
hippocampus.  
First, the calculated ratio values (NAA/Cr, Cho/Cr, NAA/Cho, Cho/NAA) are 
determined for healthy and epileptic dogs. This data was examined for a possible 
relationship between the metabolite ratios and the age and gender of the dogs. 
Second, values of the control group were compared to the epileptic dogs in the 
study group.  
Finally, the correlation between the values of the metabolite ratios in patients with 
epileptic seizures and time from the last seizure are examined. 
 
 
3.2  Materials and Methods 
 
3.2.1 Study population 
 
The study was a prospective, cross-sectional investigation. All the examined client-
owned dogs were patients of the Department of Internal Diseases with a Clinic of 
Horses, Dogs and Cats of the Faculty of Veterinary Medicine, Wroclaw University of 
Environmental and Life Sciences, Wroclaw, Poland. All the owners signed a 
declaration of consent and information about the imaging study. Magnetic resonance 
examinations were carried out in the Center of Experimental Diagnostics and 
Innovative Biomedical Technologies, The Faculty of Veterinary Medicine, Wrocław 
University of Environmental and Life Sciences, Poland.  
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3.2.2 Neurodiagnostic investigation 
 
The diagnosis of idiopathic epilepsy was based on clinical history of repeated 
seizures in dogs aged between 6 months and 6 years at the time of the first seizure 
onset, in which no known demonstrable genetic and pathologic cause has been 
found (DeLahunta & Glass, 2009). Clinical manifestation of epileptic seizures was 
documented by the owner on a video and could therefore be analysed by the 
investigators. The most frequent symptoms included jaw snapping, muscle rigidity, 
paddling of the legs, salivation, barking, jerking motions of the muscles, stiffening of 
the legs and neck and urination during or directly after the epileptic discharges. 
Some dogs showed aggression or change in the behaviour (tier I confidence level 
for the diagnosis of IE; De Risio et al., 2015). Cases suspected of paroxysmal 
events other than epileptic seizures, such as cardiogenic syncope, vestibular 
disease, narcolepsy, were excluded from the further study. The last epileptic seizure 
must have occurred within the last 4 weeks in order to investigate acute and 
subacute changes.  
Complete clinical and neurological examinations were executed by a veterinary 
neurologist on all dogs from the control and study group. Following a routine 
protocol, pre-anesthetic laboratory investigations comprised complete blood cell 
count and serum biochemistry panel, electrolytes as well as fasted ammonia testing, 
and bile acids Cerebrospinal fluid (CSF) was obtained by puncture of the atlanto-
occipital cistern with the dogs under general anaesthesia directly after the MRI 
examination. Cytologic and biochemical analysis of the cerebrospinal fluid including 
specific gravity, electrolytes, leukocyte count, complete blood count, protein 
concentration, Pandy’s reaction, glucose were performed in all dogs. (tier II 
confidence level for the diagnosis of IE; De Risio et al., 2015). Ten dogs included in 
the control group went through a complete clinical and neurological examination. 
Complete blood count, biochemistry panel, cerebrospinal fluid examination and 
urinalysis was obtained in all dogs. They had no history of epileptic seizures. All 
dogs were presented for MR imaging for other clinical problems, mostly spinal cord 
abnormalities, and were aged between 1 to 4 years.  
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3.2.3 Anaesthesia protocol 
 
 All MRI and MRS were proceeded under premedication followed by general 
anaesthesia. Each patient underwent premedication using medetomidine (0,02 
mg/kg i.m) and butorphanol (0.1 mg/kg i.m). The patients were intubated and 
positioned in a sternal recumbency. General anaesthesia was induced with Propofol 
(4-8 mg/kg i.v) and maintained by inhaled anaesthetics (1-3 Vol % Sevoflurane in 
oxygen).  
 
3.2.3 Magnetic Resonance Imaging (MRI) 
 
All MRI and MRS data were acquired in ventral recumbency with a high-field 1.5 
Tesla MR scanner (Ingenia; Philips Medical Systems, 2013) using dStream 
HeadSpine coil (Philips Medical Systems, 2013). The following MRI pulse 
sequences were applied:  2 mm T2-weighted spin echo (SE) images, 2 mm fluid-
attenuated inversion recovery (FLAIR) sequence, 0.8 mm T1- weighted 3D pre- and 
post- contrast images following intravenous administration of gadolinium 
(Gadobutrol 604.72 mg/mol). All MR sequences were performed as follows: 
conventional transverse and sagittal T2-weighted images (TR 4423.5 ms/ TE 100 
ms), dorsal FLAIR (TR 9000ms/ TE 140 mg), 3D T1- weighted pre- and postcontrast 
images (TR 25ms/ TE 5.1 ms).  
 
3.2.4 Magnetic Resonance Spectroscopy (MRS) 
 
Single-voxel proton magnetic resonance spectroscopy was performed during the 
MRI study before intravenous administration of the contrast medium. The MRSI 
studies were targeted to suspected regions of interest (temporal lobe, hippocampal 
area) for seizure localization. A cubic voxel (10 x 10 x 10 mm3) was identical for all 
studies and positioned manually, bilaterally, symmetrically at thin, 2mm T2-weighted 
sagittal and transverse, 0.8 mm T1- weighted 3D pre- contrast dorsal into the region 
of left and right temporal lobe including a posterior part of hippocampus and 
amygdala (Figure 10).  
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Figure 10: Transverse (A) and dorsal (B) T2-weighted MR images showing the position of 
point-resolved spectroscopy voxel (10 x 10 x 10 mm3) for  the right side. The identical 
examination was performed for the left side. 
 
 
The great caution was exercised when placing the voxel in order to prevent scalp fat 
and CSF contamination. The method of a point resolved spectroscopy sequence 
(PRESS) with chemical-shift selective (CHESS) pulse for water suppression 
(bandwidth 50 Hz) was obtained. The MRSI studies were acquired  as Hahn spin 
echoes with repetition time [TR], 2000 milliseconds; echo time [TE], 144 
milliseconds; the number of phase-encoding steps [NP], 1024. A total of 256 images 
were averaged for an acquisition time of 10 min for each investigated side of the 
mesial temporal/ hippocampal area. The accurate position of the voxel for each 
examination was controlled by the doctoral student (AO) and approved by the 
supervisor (MS). 
 
 
3.2.6 Data processing and quantification 
 
An automatic and operator-nondependent data processing system was used to 
obtain the spectra recorded for the analysis (SpectroView Analysis software, Philips 
Healthcare). The spectral post-processing included the adjustment of the base-line, 
the noise level reduction, and metabolite peak calibration, correction of the internal 
water referencing and the application of spectral plotting, followed by Fourier 
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transformation. Spectra were phased and fit in the spectral domain followed by 
Gaussian line-shaped transformation. 
1HMRS data with relatively unstable baseline despite post-processing techniques 
used suggesting either the involvement of the nuisance signals such as  
water, lipids or poor spatial localisation of the voxel, were excluded manually by 
doctoral student (AO) from further analysis. The following signals of metabolite 
peaks in the applied long echo time sequences were detected: N-acetylaspartate 
(NAA) at 2.02 ppm, choline (Cho) at 3.22 ppm and creatine (Cr) at 3.02 ppm. The 
NAA, Cho and Cr peaks were identified upon their ppm scale, volume and 
localisation (Figure 11). The obtained data was correlated with the animal reference 
values (Carrera, et al., 2014). NAA-to-choline ratio, NAA-to-creatine ratio, and 
choline-to-creatine and choline-to-NAA ratio were automatically calculated using 
resonance areas for both groups of dogs. Both groups were compared and the 
results were correlated with the available references from Warrington (Warrington et 
al., 2013). 
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Figure 11: Single spectrum from an individual voxel placed at the level of temporal lobe 
including an posterior part of hippocampus showing metabolite peaks of NAA at 2.0 ppm, Cr 
at 3.0 ppm, Cho at 3.2 ppm and the calculated metabolite ratios in a mixed breed dog with 
degenerative disc disease included in the control group (A) and in 5 year old mixed breed 
male dog with idiopathic epilepsy and last seizure 5 days ago (B). The correlation between 
NAA, Cr and Cho metabolite peak varies between two dogs. 
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3.2.7 Statistical analysis 
 
The collected data were analysed using statistical software (BMDP/ Dynamic, 
Statistical Software, Inc., Release 8.1). Descriptive statistics were calculated for 
peak area ratios at MR spectroscopy. The statistical evaluation included 4 
metabolite ratios (NAA-to-choline ratio, NAA-to-creatine ratio, and choline-to-
creatine and choline-to-NAA ratio) evaluated equally for both groups. The summary 
statistics over all cases and broken down by individual category on the group, was 
performed. The mean, standard deviation (SD), standard error of the mean (SE), 
the coefficient of variation (CV) the smallest value, the largest value and range were 
calculated for every category group including all dogs, age of dogs and all 
metabolite ratios (NAA-to-choline ratio, NAA-to-creatine ratio, choline-to-creatine 
and choline-to-NAA ratio) for the left and right side (amygdala und a posterior part of 
the hippocampus). 
A two-factor repeated measures ANOVA test with respect to a side was used to 
compare the ratio values of the healthy dogs in the control group to the epileptic 
dogs in the study group. The cell mean, standard deviation and the analysis of 
variance was calculated for every dependent variable (DV) (NAA/Cr, Cho/Cr, 
NAA/Cho, Cho/NAA). An explorative data analysis was carried out to verify the 
relationship between the age (covariate) and gender (additional grouping) of canines 
and the metabolite ratio in different group variants.  
A three-factor analysis of covariance (ANCOVA) with repeated measure with respect 
to a side was used to examine the correlation between the metabolite ratios and the 
age and sex of the diseased dogs. The same analysis was performed in the control 
group. 
Single-factor analysis of covariance (ANCOVA) with repeated measures was applied 
to examine the correlation between the values of the metabolite ratios in dogs with 
epileptic seizures and time from the last seizure. The normal distribution was given 
for all variables, approximately. The level of significance (p) was considered 
significant < 0.05 for all applied tests. 
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4. Results 
 
Twenty- seven dogs with idiopathic epilepsy met the inclusion criteria for our study. 
A list of dog breeds, their age and gender in the groups are summarised below 
(Table 1). All epileptic dogs (100%) showed no structural lesions in the MRI. Of ten 
dogs included in the control group, four were diagnosed with syringomyelia (40%), 
three with degenerative disc disease (30%), two with fibrocartilaginous embolism 
(20%) and one with spine trauma (10%). Table 2 presents the number of the dogs in 
the control group. Of twenty-seven canines in the study group, fifteen were male 
(56%) and twelve were female (44%), whereas in the control group three were male 
(30%) and seven female (70%). All dogs in the study group showed generalized 
tonic-clonic seizures with bilateral involvement, salivation and urination.  
Seventeen dogs from the study group (63%) were categorised as with possible 
acute changes (≥ 14 days from the last seizure) while ten dogs (37%) with possible 
subacute changes (< 14 days the last seizure) (Figure 12). 
The data for all variables (NAA/Cr, Cho/Cr, NAA/Cho, Cho/NAA) calculated for the 
control and diseased group were reviewed. All metabolite ratios calculated for the 
dogs in control and the study group are listed below (Table 3, 4). 
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Table 1: Number of different breed dogs comprised in the study group. Data included breed, 
sex, age in years and the time in days from the last seizure observed. 
 
Breed Sex Age in years  Days from the last seizure 
Bavarian Mountain dog M 4 21 
Central Asian Shepherd dog F 2 27 
Berger Blanc Suisse M 2.5 2 
Berger Blanc Suisse M 2 20 
Siberian Husky F 3.5 28 
Beagle M 2 20 
French bulldog M 3 12 
French bulldog F 3 9 
Bull terrier M 5 1 
Bull terrier M 2 1 
Mixed breed  M 5 7 
Mixed breed  F 5 14 
Dogo Argentino M 1.5 15 
Cocker spaniel F 4 14 
Border collie F 1 21 
Border collie F 7 4 
Miniature pinscher F 1.6 7 
Labrador retriever F 3 0 
Labrador retriever M 1.5 1 
Golden retriever M 7 14 
Hungarian Vizsla F 3 15 
American Staffordshire terrier M 2 7 
American Staffordshire terrier M 7 0 
Staffordshire Bull terrier M 2 7 
Mixed breed F 7 14 
Mixed breed F 7 15 
Rottweiler M 2 28 
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Table 2: Dogs included in the control group. Data included breed predilection, sex, age and 
the diagnosis made based on the magnetic resonance examination. 
 
Breed Sex Age in years The reason for MRI 
West Highland White terrier M 3 Degenerative disc disease 
Cavalier King Charles spaniel F 2.4 Syringomyelia 
Mixed dolichocephalic breed M 4 Degenerative disc disease 
Maltese F 3.5 Syringomyelia 
Labrador retriever F 2 Fibrocartilaginous embolism  
Cavalier King Charles spaniel F 3 Syringomyelia 
West Highland White terrier F 1 Spinal trauma  
Cavalier King Charles spaniel F 2.5 Syringomyelia 
French bulldog F 3 Degenerative disc disease 
Labrador retriever M 2.5 Fibrocartilaginous embolism  
 
 
 
 
Figure 12: Graph showing a distribution of epileptic convulsions in relation to time from last 
seizure in dogs from the study group. Seventeen dogs were categorised as with possible 
acute changes while ten dogs with likely subacute changes. 
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Notable variations in the mean value of all variables (NAA/Cr, Cho/Cr, NAA/Cho, 
Cho/NAA) were observed among study and control group. NAA/Cr ratio had a mean 
value of 1.35 in the study group, whereas 1.44 in the control group. Cho/Cr ratio had 
a mean value of 1.28 in the study group, while 1.25 in the control group. NAA/Cho 
ratio had a mean value of 1.09 in the study group, whereas 1.16 in the control group. 
Cho/NAA ratio had a mean value of 0.95 in the study group, while 0.88 in the control 
group (Figure 13). 
 
 
Figure 13: Graphs presenting the variations in metabolite mean values (NAA/Cr, Cho/Cr, 
NAA/Cho, Cho/NAA) between the control and epileptic dogs obtained in the region of left and 
right temporal lobe including a posterior part of hippocampus and amygdala. 
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A summary of metabolite ratios, mean and standard deviation, standard error of the 
mean, the coefficient of variation, the smallest value, the largest value in both 
groups is presented in Table 5.  
 
 
 
4.1 Comparison of the metabolite ratios between the control and diseased 
group 
 
No significant differences were observed, when comparing the metabolite ratios 
(NAA/Cr, Cho/Cr, NAA/Cho, Cho/NAA) between the control and diseased group. 
NAA/Cr had a level of significance (p) at 0.228, Cho/Cr at 0.228, NAA/Cho at 0.314 
and Cho/NAA at 0.251 (Table 6). Moreover, the ratios for left and right region of 
interest similarly did not vary significantly between examined groups. Cho/Cr had a 
level of significance at 0.794, NAA/Cho at 0.149, Cho/NAA at 0.103. However, 
NAA/Cr value almost reached statistical difference (p= 0.072). 
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Table 6: Comparison of the metabolite ratios (NAA/Cr, Cho/Cr, NAA/Cho, Cho/NAA) between 
the control and diseased group. The examined ratios for left and right region of interest 
similarly showed no significant difference between groups. 
 
 
 
 
4.2 Correlation between the metabolite ratios and the age and sex  
 
There was no significant decrease with advancing age for all examined metabolite 
ratios (NAA/Cr, p= 0.598; Cho/Cr, p= 0.862; NAA/Cho, p= 0.898; Cho/NAA, p= 
0.788). 
Similarly, no significant correlation between sex of the examined dogs was 
observed, when comparing the metabolite ratios in the control and diseased group 
(NAA/Cr, p=0.0633; Cho/Cr, p= 0.517; NAA/Cho, p=0.065; Cho/NAA, p=0.063).  
Statistics data is presented in Table 7.
Main effects 
Metabolite 
ratio 
Comparison between 
groups 
Comparison between 
the sides 
Interaction between the effect 
on the group and side 
  p value p value  p value  
NAA/Cr  0.228 0.072 0.866 
Cho/Cr  0.228  0.794 0.474 
NAA/Cho 0.314 0.149 0.808 
Cho/NAA  0.251 0.103 0.728 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
64
 
 
Ta
bl
e 
7:
 A
 th
re
e-
 fa
ct
or
 a
na
ly
si
s 
of
 c
ov
ar
ia
nc
e 
(A
N
C
O
VA
) w
ith
 r
ep
ea
te
d 
m
ea
su
re
 w
ith
 r
es
pe
ct
 to
 a
 s
id
e 
us
ed
 to
 e
xa
m
in
e 
th
e 
co
rr
el
at
io
n 
be
tw
ee
n 
th
e 
m
et
ab
ol
ite
 r
at
io
s 
an
d 
th
e 
ag
e 
an
d 
se
x 
of
 t
he
 d
is
ea
se
d 
do
gs
. 
N
o 
si
gn
ifi
ca
nt
 d
iff
er
en
ce
s 
in
 m
et
ab
ol
ite
 r
at
io
s 
w
er
e 
fo
un
d 
w
he
n 
co
m
pa
rin
g 
he
al
th
y 
an
d 
di
se
as
ed
 g
ro
up
 re
ga
rd
in
g 
ag
e 
an
d 
se
x.
 
  
M
ai
n 
ef
fe
ct
s 
In
te
ra
ct
io
ns
 
M
et
ab
ol
ite
 
ra
tio
 
G
ro
up
 
Se
x 
Si
de
 
gr
ou
p 
x 
se
x
gr
ou
p 
x 
si
de
 
se
x 
x 
si
de
 
se
x 
x 
gr
ou
p 
x 
si
de
 
C
ov
ar
ia
te
 
ag
e 
 
p 
va
lu
e 
p 
va
lu
e 
p 
va
lu
e 
p 
va
lu
e 
p 
va
lu
e 
p 
va
lu
e 
p 
va
lu
e 
p 
va
lu
e 
N
A
A
/C
r 
0.
61
5 
0.
06
3 
0.
06
4 
0.
06
3 
0.
88
1 
0.
26
 
0.
91
8 
0.
59
8 
C
ho
/C
r 
0.
85
6 
0.
51
7 
0.
77
8 
0.
78
1 
0.
62
1 
0.
38
7 
0.
73
3 
0.
86
2 
N
A
A
/C
ho
 
0.
80
7 
0.
06
5 
0.
16
8 
0.
17
6 
0.
73
2 
0.
62
3 
0.
97
6 
0.
89
8 
C
ho
/N
A
A
 
0.
65
4 
0.
06
3 
0.
10
8 
0.
19
4 
0.
67
2 
0.
83
2 
0.
71
2 
0.
78
8 
   
                                                      65 
 
4.3 Correlation between the metabolite ratios and the time from the last seizure 
in the group of the diseased dogs 
 
When interpreting the estimated regression coefficients, NAA/Cr and NAA/Cho ratios 
tend to decrease over time.  In contrary, the values of Cho/Cr and Cho/NAA ratios 
increase with advancing time from the last seizure. 
An interesting association was found between two metabolite ratios (NAA/Cho, 
Cho/NAA) and time from the last epileptic convulsion. NAA/Cho ratio decreased 
significantly with advancing time from last seizure (p= 0.03). Equally, Cho/NAA ratio 
was significantly lower (p= 0.01) in dogs with recent seizures and was increasing 
within time.  
NAA/Cr and Cho/Cr ratios showed no significant difference over time from the last 
seizure (Table 8). However, NAA/Cr ratio in relation to a side showed a significant 
correlation at p=0.054. 
 
 
 
Table 8: Significant positive correlation found between NAA/Cho ratio (p= 0.03) and Cho/NAA 
ratio (p= 0.01) and time from last seizure in comparison to the control group. Calculated 
regression coefficients show, how the metabolite ratio decreases (NAA/Cr, NAA/Cho) and 
increases (Cho/Cr, Cho/NAA) over time. Significant differences are highlighted in red. 
 
 
 Main effects  
Metabolite ratio  Last seizure Side Regression coefficients
 p value p value    
NAA/Cr  0.121 0.054 -0.005 
Cho/Cr  0.169 0.364 0.006 
NAA/Cho 0.026 0.275 -0.008 
Cho/NAA  0.009 0.243 0.008 
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5. Discussion 
 
In this study, we present data of interictal single-voxel MRSI of the temporal region 
in dogs with idiopathic epilepsy and structurally normal brain. No significant changes 
of investigated metabolite ratios were observed in the study cohort compared to 
controls. A relation between metabolite ratios and the time from the last seizure was 
found, i.e., the closer MRSI was obtained from the time of the last seizure, the 
higher was NAA/Cho ratio. NAA is one of the most abundant amino acids in the 
central nervous system. It is believed to be located primarily within neurons, where it 
is involved in energy metabolism (Miyake et al., 1981). It was also suggested to play 
a role in in the synthesis of myelin and lipids in the central nervous system (Moffett 
et al., 2007).  Loss of NAA signals is considered to be consistent with loss of 
neuronal integrity, but it can also be used as a marker of impaired neuronal function 
and reduced oxidative metabolism (Woermann et al., 1999). Concentrations of Cho 
and Cr are higher in astrocytes, which is why the change in the NAA/Cho and 
NAA/Cr ratios are considered to reflect neuronal loss and reactive astrocytosis as in 
humans with hippocampus sclerosis (Kendall et al., 2014; Stagg et al., 2013; 
Mellema et al., 1999).   
In human patients with epilepsy, spectroscopic studies of the hippocampus are 
mainly used to determine lateralization of the epileptogenic zone in one temporal 
lobe. Unilateral decrease of NAA/Cr, NAA/Cho, or NAA/Cr ratios showed good 
concordance with localization of the epileptogenic zone in the respective 
hippocampus (Hetherington et al., 1995; Li et al., 2000) and predicts positive 
surgical outcome (Suhy et al., 2002). Furthermore, resection of the hippocampus is 
also performed in patients with structural or functional extra-temporal seizure foci if 
changes in the hippocampus can be detected (Condon et al., 2011; Li et al., 1997; Li 
et al., 1999). The presence of hippocampal damage and/or dysfunction, in 
association with a lesion outside the temporal lobe, is assumed to be due to 
propagation of epileptogenic activity from the remote focus into the hippocampus 
formation inducing secondary epileptogenic effects (Miller et al., 2000). Interictal 
spectroscopic examination revealed reduced hippocampal NAA/Cr and NAA/Cho in 
humans with extra-temporal epilepsy (Miller et al., 2000; Mueller et al., 2006). 
Surgical resection of the hippocampus can significantly reduce the seizure 
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frequency in these patients, which underlines the role of hippocampal propagation of 
seizure activity in presence of an extratemporal focus (Levesque et al., 1991).  
Our understanding of epilepsy in dogs is still limited and somewhat focused on the 
existence of primary temporal lobe epilepsy (Hasegawa et al., 2016). However, the 
proof of any negative effect of the hippocampus on seizure generation or 
enhancement in epileptic dogs might take us a step forward and might encourage 
veterinary neurosurgeons to consider resection of the temporal lobe in dogs with 
refractory epilepsy (Estey et al., 2017). The finding of this study, namely that 
generalized tonic-clonic seizures do not create changes in metabolic spectra 
measured in the hippocampus, suggests that repeated seizures do not cause 
secondary damage to the hippocampus in dogs. However, the fact that other studies 
documented functional or structural changes of the hippocampus (Czerwik et al., 
2018; Estey et al., 2017; Hartmann et al., 2017; Kuwabara et al., 2010) warrants 
further investigations using MRSI.  
The role of the hippocampus and the presence of primary temporal lobe epilepsy in 
dogs is still a matter of debate. Although some evidence exists for some role of the 
temporal structures in the propagation and/or initiation of electrical activity 
(Montgomery et al., 1983; Yamasaki et al., 1991), no data has been published on 
the larger group of epileptic dogs. However, there is growing number of reports in 
veterinary medicine about temporal structures and their functional abnormalities 
including EEG abnormalities (Berendt et al., 1999;  Czerwik et al., 2018; Hasegawa 
et al., 2003), MRI changes such as hyperintensity, hippocampal necrosis 
(Hasegawa, 2005), volume loss and ADC increase in diffusion weighted imaging 
(Hartmann et al., 2017; Kuwabara et al., 2010; Vullo et al., 1996 ).  
In the histopathological examinations of the hippocampus typical findings include 
neuronal loss, most severely in the hilus of the dentate gyrus, axon reorganisation, 
hippocampal atrophy and sclerosis, temporal lobe sclerosis, cytotoxic oedema and 
gliosis. These variations and their functional consequences occur as a primary 
lesion that is the consequence of unknown insults, but can also arise as a secondary 
lesion after seizures originating elsewhere in the brain of humans and cats (Wagner 
et al., 2014). Macroscopically, hippocampal sclerosis can be characterized by an 
atrophic, small hippocampus that can be seen in MRI. Visual assessment of 
hippocampal atrophy that can be confirmed by postprocessing volumetric 
                                                      68 
 
techniques is usually the first feature indicating structural changes of the 
hippocampus (Wrzosek et al., 2016).  
In humans, temporal lobe epilepsy with hippocampal sclerosis has a characteristic 
seizure semiology. A variety of autonomic and emotional symptoms can occur in the 
preictal phase, the complex partial seizure typically begins with motor arrest and 
staring followed by oroalimentary automatisms (e.g., lip-smacking, chewing) and 
other purposeless movements (Engel et al., 2006; Williamson et al., 1998). 
Secondary generalizations of seizures are frequently observed. Similar clinical 
findings were already documented in some dogs (Hasegawa et al., 2003; 2005) 
describing the temporal lobe to be the symptomatogenic region of seizure 
involvement. In the present report, all dogs included in the study group showed 
symptoms of jaw snapping, muscle rigidity, paddling of the legs, salivation, barking, 
jerking motions of the muscles, stiffening of the legs and neck, which can occur in 
primary temporal lobe epilepsy. Aggression, fear and other behavioural changes 
followed by secondary generalization of seizures were also mentioned which could 
suggest the involvement of temporal structures (Hasegawa et al., 2005; Mellema et 
al., 1999). The primary origin of the hippocampus in the seizure events therefore 
cannot be excluded.  
 
 
5.1 Limitations of the study 
 
The results of our study might have been biased due to a number of reasons. 
Although we could not document a correlation between the duration of seizure 
activity before imaging, influence of seizure frequency and duration cannot be ruled 
out. Humans with TLE studied within 24 hours postictal period showed no changes 
in the metabolite ratios suggesting that this ratio is insensitive to immediate seizure 
history (Cendes et al., 1997; Maton et al., 2001). Another study found no relationship 
between NAA/Cho, NAA/Cr and seizure duration, frequency, or lifetime estimated 
seizures (Warrington et al., 2013). We found a correlation between time duration to 
the last seizure and decrease of NAA/Cho. If all dogs would have been examined at 
comparable time duration to the last seizure, the differences in the metabolite ratios 
might have become significant. The difference between ratios between left and right 
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hippocampal formation almost reached significance, which might also increase with 
standardized imaging modalities. These possible connections should be further 
investigated. 
We decided for single voxel measurement as it provides volume selectivity of the 
acquired signal and therefore high signal-to-noise ratio resulting in high-quality 
spectra suitable for quantitative analysis. However, using single-voxel acquisition, it 
was technically not possible to reduce the voxel < 1 cm in size. Therefore, the 
spectra were not measured exclusively in the temporal lobe, but contained 
information from adjacent brain tissue, especially from the thalamus. This was 
technically unavoidable because of the placement of the voxel outside of the 
margins of the brain, thus overlapping the calvaria and producing poor-quality 
spectra due to fat contamination (Ober et al., 2013). However, this can be seen as a 
systematic error that occurred in every examined dog. 
Multivoxel acquisition techniques offer the advantage of examining smaller regions 
of interest, which is important when studying small or irregularly shaped anatomic 
structures as the hippocampus formation. However, spectral contamination from 
adjacent voxels can have a high influence on the values, which makes quantification 
of the spectra difficult. Ratios determined by Warrington, obtained in the temporal 
lobe of 10 healthy beagles were higher than in our control group (Warrington et al., 
2013). Both absolute values and NAA/Cho, NAA/Cr and Cho/Cr ratios have a larger 
range and median values, which probably reflect the differences of single- vs 
multivoxel acquisition. Systematic comparison between spectroscopic data obtained 
by single- and multi-voxel acquisition has been performed in dog cadavers (Ober et 
al., 2013). According to the recent preliminary findings (Lee et al., 2018), single- and 
multi-voxel spectroscopy techniques yield comparable results for similar sized 
regions of interest in the normal canine brain.  
The absolute metabolite quantification can be obtained in two different ways: as 
ratios or absolute metabolite concentrations. The results of our spectra are 
expressed in terms of ratios which are considered to be a more stable indicator to 
describe parenchymal changes (Li et al., 2003; Kuzniecky et al., 2015). The major 
disadvantage of the quantification as absolute metabolite concentrations is that 
several advanced spectral fitting techniques measured by dedicated software must 
be carried on in order to obtain relevant measurements. 
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We decided to use the long echo time PRESS sequence because of the improved 
signal intensity–to-noise ratio and a more readable spectrum which contains less 
signal from the lipid and metabolites with short T2 values, thus helps to interpret the 
spectrum. In contrary, STEAM technique is obtained using shorter echo times which 
enables detection of small metabolites with shorter T2 times (Castillo et al., 1996; 
Kwock et al., 1998). Further studies examining PRESS and STEAM techniques 
simultaneously need to be performed. 
It is also unclear as to whether the measured spectra and ratios might be breed 
specific, or breed specifically biased. We included brachycephalic dogs to our 
control group. The brains of these dogs are somewhat distorted, which might have 
caused slightly different tissue components in the examined voxels. Hippocampal 
volume differs significantly in size in allometric relationships to brain- and 
bodyweight. Comparisons between larger cohorts of homogenous groups of dogs of 
the same breed will be necessary to prove such a breed influence on MRSI spectra. 
In humans, metabolite ratios can differ along the long axis of the hippocampus with 
lower ratios of NAA/Cho and NAA/Cr in the anterior as compared with the posterior 
part of the hippocampus (Vermathen et al., 2000). We examined only a posterior 
part of the hippocampus, therefore further studies are needed to compare it to the 
other area.  
Last, the MRI of the control group was performed after examination of other body 
parts, which likely increase time under general anaesthesia and therefore could 
possibly alter brain metabolism.  
The variability of the technical parameters used for spectroscopic investigations and 
the absence of standard criteria for dogs both for spectral acquisition and data 
analysis make the interpretation of results of magnetic resonance spectroscopy in 
veterinary patients challenging.  
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6. Conclusion 
 
Interictal single voxel proton magnetic resonance spectroscopy (1HMRS) of the 
temporal region in dogs with idiopathic epilepsy and structurally normal MRI 
revealed no statistically relevant changes in examined metabolite ratios (NAA/Cr, 
Cho/Cr, NAA/Cho, Cho/NAA) in comparison to the healthy group. NAA/Cho ratios 
negatively correlate with time duration to seizure. 
 
7. Summary 
 
Single voxel proton magnetic resonance spectroscopy is a promising diagnostic tool 
for use in dogs with idiopathic epilepsy und structurally normal brain. We did not 
observe variations in the investigated metabolite ratios in the IE group compared to 
the controls. Moreover, no age and sex related differences in metabolite ratios were 
noted. However, there is strong evidence for a relation between metabolite ratios and 
the time from the last seizure. Our data strongly suggests, that further MRS studies 
should be obtained on dogs in the ictal period. Magnetic resonance spectroscopy 
presents an additional value for  the diagnosis of the canine idiopathic epilepsy and 
could help to localize the epileptogenic region in the future. 
 
8. Zusammenfassung 
 
Die Single- Voxel- Protonen- Magnetresonanz- Spektroskopie ist ein 
erfolgversprechendes Diagnosewerkzeug für Hunde mit idiopathischer Epilepsie und 
strukturell normalem Gehirn. In den untersuchten Metabolitenverhältnissen- in der 
Gruppe mit idiopathischer Epilepsie- haben wir im Vergleich zur Kontrollgruppe keine 
Unterschiede beobachtet. Darüber hinaus wurden keine alters- und 
geschlechtsspezifischen Unterschiede in den Metabolitenverhältnissen festgestellt. 
Es gibt jedoch deutliche Belege für einen Zusammenhang zwischen 
Metabolitenverhältnissen und der Zeit seit dem letzten epileptischen Anfall. Unsere 
Daten deuten stark darauf hin, dass weitere MRS-Studien an Hunden in der iktalen 
Phase durchgeführt werden sollten. Die Magnetresonanzspektroskopie stellt einen 
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zusätzlichen Wert für die Diagnose der idiopathischen Epilepsie beim Hund dar und 
könnte dazu beitragen, die epileptogene Areal in Zukunft zu lokalisieren. 
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